期刊文献+

硝苯地平控释片联合奥美沙坦治疗老年人原发性高血压66例疗效分析 被引量:4

下载PDF
导出
摘要 高血压病是临床常见病和多发病,分为原发性高血压和继发性高血压,其中原发性高血压占95%以上,是心脑血管疾病的重要危险因素之一,可引起脑出血、脑梗塞、冠心病、心力衰竭和慢性肾衰等多种并发症。随着我国人口老龄化加剧,我国老年人原发性高血压发病率高达57%,已成为受高血压危害最严重的国家之一,引起医学界的广泛关注。高血压的治疗药物主要有四种:ACEI/ARB类、B受体阻滞剂、钙通道阻滞剂和利尿剂,每种药物的作用机制不同。2005年,中国高血压防治指南建议联合降压治疗提高血压达标率,联合治疗方案众多,其中ACEI/ARB类联合钙通道阻滞剂是较常用的联合用药方案之一。
作者 蒋晓发
出处 《中国初级卫生保健》 2014年第8期100-101,共2页 Chinese Primary Health Care
  • 相关文献

参考文献5

二级参考文献28

  • 1中华人民共和国卫生部心血管病研究中心.中国高血压防治指南(2009年修订版)[M].北京:人民卫生出版社,2009:85-8.
  • 2Wald DS,Law M,Morris JK,et al.Combination therapy versus monotherapy in reducing blood pressure:meta-analysis on 11 000participants from 42trials[J].Am J Med,2009,122(3):290-300.
  • 3ALLHAT officers and coordinators for the ALLHAT collabora-tive research group.The Antihypertensive and lipid-lowering treatment to prevent heart attack trial.Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic:The anti-hypertensive and lipid-lowering treatment to prevent heart attack trial(ALLHAT)[J].JAMA,2002,288(23):2981-2997.
  • 4Hansson L,Zanchetti A,Carruthers SG,et al.Effects of inten-sive blood-pressure lowering and low-dose aspirin in patients with hypertension:principal results of the hypertension optimal treat-ment(HOT)randomised trial.HOT study group[J].Lancet,1998,351(9118):1755-1762.
  • 5Gradman AH,Basile JN,Carter BL,et al.On behalf of the A-merican society of hypertension writing group ASH position arti-cle combination therapy in hypertension[J].J Am Soc Hypertens,2010,4(1):42-50.
  • 6Neutel JM,Franklin SS,Oparil S,et al.Efficacy and safety of irbesartan/HCTZ combination therapy as initial treatment for rapid control of severe hypertension[J].J Clin Hypertens,2006,8(12):850-857.
  • 7Sowers JR,Neutel JM,Saunders E,et al.Efficacy of irbesartan/HCTZ in men and women with the metabolic syndrome and type 2diabetes[J].J Clin Hypertens(Greenwich),2006,8(7):470-480.
  • 8Feldman RD,Zou GY,Margaret K,et al.A simplified approach to the treatment of uncomplicated hypertension a cluster random-ized,controlled trial[J].Hypertension,2009,53(4):646-653.
  • 9Neteul JM.A comparison of the efficacy and safety of irbesartan/hydrochlorothiazide combination therapywith irbesartan mono-therapy in the treatment of moderate or severe hypertension in diabetic andobese hypertensive patients:apost-hoc analysis review[J].Postgrad Med,2011,123(4):126-134.
  • 10REILLY M P,LEHRKE M,WOLFE M L,et al.Resistin is aninflammatory marker of atherosclerosis in humans[J].Circulation,2005,22,111(7):932-939.

共引文献62

同被引文献41

  • 1吴龙光.奥美沙坦酯治疗轻度及中度原发性高血压疗效和安全性的评价[J].医学信息(医学与计算机应用),2014,0(23):547-548. 被引量:2
  • 2谢文虎.血管紧张素转换酶抑制剂联合血管紧张素受体拮抗剂治疗心力衰竭的临床疗效分析[J].实用心脑肺血管病杂志,2015,23(2):121-122,125.
  • 3Chang P Y , Qin L , Zhao P , et al. A ssociation of regulatorof G protein signaling (R G S 5) gene variants andessential hypertension in M ongolian and H an population s[J]. G enet Mol R es, 2 01 5,14 (4 ) : 17641-17650.
  • 4W ang G ,X u P ,F en g W ,e t al. Case-control study on peroxisome proliferator-activated receptor gamma polym orphismand interaction w ith H D L on essential hypertensionin Chinese H a n [J]. Iran J Basic Med S ci,20 1 5,18(1 2 ):1228-1232.
  • 5Stolarz-Skrzypek K. Discovering the genetic basis of essentialhypertension: hypes and hopes [J] . Pol A rchM ed W ew n ,2015,125(12) :891-893.
  • 6Xiao C f Yang Y , Zhuang Y. Effect of health Qigong BaD uan Jin on blood pressure of individuals w ith essentialhyp erten sio n[J]. J A m G eriatr S oc, 2016,64 (1 ) : 211213.
  • 7So laym an M H , Langaee T , Patel A , et al. Identificationof suitable endogenous norm alizers for qRT-PC Ranalysis of plasm a m icroRN A expression in essential hypertension[J]. Mol B iotechnol,2016,5 8 (3 ) :179-187.
  • 8Pandey P , M oham m ad G , Singh Y , et al. Polym orphisms and haplotype of ROCK2 associate w ith high altitudeessential hypertension in native high altitudeLadakhi Indian population: a prelim inary stu d y [J]. ClinExp H y p e rte n s,2 01 6,38 (2 ) :238-244.
  • 9H andley A , Lloyd E , R oberts A , et al. Safety and tolerabilityof azilsartan medoxomil in subjects w ith essenhttp://tial hypertension: a one-year, phase 3 , open-label study[J]. Clin Exp H y p e rte n s,2 01 6,38 (2 ) : 180-188.
  • 10Li M , Zhang B, Li C , et al. T he A ssociation of m itofusion-2 gene polym orphism s w ith susceptibility of essentialhypertension in N orthern H an Chinese population[J]. Int J Med S c i,2 0 1 6 ,1 3 (l):39-47.

引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部